Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending May 2013. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding changes in share interests.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of a specific share transaction rather than a financial performance report.
Material Changes
The filing details a transaction on May 10, 2013, involving Mr. P C Thomson and his connected person, Mrs. K Thomson. Through the Company's ShareReward Plan, they acquired Ordinary Shares at a price of 1662.09 pence per share. The transaction consisted of:
- Acquisition of 1 Ordinary Share under the personal contribution element of the Plan.
- Acquisition of 1 Ordinary Share under the matching element of the Plan (Company contribution).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the notification of the share transaction in accordance with Disclosure and Transparency Rule 3.1.4R(1)(c).
Key Facts for Investor Verification
- Transaction Date: May 10, 2013.
- Share Price: 1662.09 pence per Ordinary Share.
- Parties Involved: Mr. P C Thomson and Mrs. K Thomson.
- Total Shares Acquired: 2 Ordinary Shares (1 personal, 1 company match).
- Notification Date: May 13, 2013.